Claudia A. Collier
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Claudia A. Collier has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Shreya Raghavan
Department of Biomedical Engineering, Texas A&M University, College Station, USA
30 shared publications - Abigail J. Clevenger
Department of Biomedical Engineering, Texas A&M University, College Station, Texas
28 shared publications - Amber N. Stratman
Department of Cell Biology and Physiology, Washington University in St. Louis
28 shared publications - John Paul M. Gorley
Department of Biomedical Engineering, Texas A&M University, College Station, Texas
28 shared publications - Maygan K. McFarlin
Department of Biomedical Engineering, Texas A&M University, College Station, Texas
28 shared publications - Sarah Colijn
Washington University School of Medicine
28 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Oncogenic KRAS Mutations Confer a Unique Mechanotransduction Response to Peristalsis in Colorectal Cancer Cells
Supplementary Table 2 contains all target sequencies of CRISPR reagents used in this work.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Oncogenic KRAS Mutations Confer a Unique Mechanotransduction Response to Peristalsis in Colorectal Cancer Cells
Supplementary Table 2 contains all target sequencies of CRISPR reagents used in this work.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from Oncogenic KRAS Mutations Confer a Unique Mechanotransduction Response to Peristalsis in Colorectal Cancer Cells
Supplementary Figure 5 demonstrates the manual quantification of β-Catenin nuclear localization in ImageJ.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from Oncogenic KRAS Mutations Confer a Unique Mechanotransduction Response to Peristalsis in Colorectal Cancer Cells
Supplementary Figure 5 demonstrates the manual quantification of β-Catenin nuclear localization in ImageJ.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 9 from Oncogenic KRAS Mutations Confer a Unique Mechanotransduction Response to Peristalsis in Colorectal Cancer Cells
Supplementary Figure 9 shows direct comparisons of LGR5 expression for inhibition conditions for all cell types tested.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 9 from Oncogenic KRAS Mutations Confer a Unique Mechanotransduction Response to Peristalsis in Colorectal Cancer Cells
Supplementary Figure 9 shows direct comparisons of LGR5 expression for inhibition conditions for all cell types tested.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Oncogenic KRAS Mutations Confer a Unique Mechanotransduction Response to Peristalsis in Colorectal Cancer Cells
Supplementary Table 1 contains the mutation status of all cell and PDX lines tested in this work.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Oncogenic KRAS Mutations Confer a Unique Mechanotransduction Response to Peristalsis in Colorectal Cancer Cells
Supplementary Table 1 contains the mutation status of all cell and PDX lines tested in this work.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Oncogenic KRAS Mutations Confer a Unique Mechanotransduction Response to Peristalsis in Colorectal Cancer Cells
Supplementary Figure 1 shows the gating strategy used for LGR5 analysis in Figures 1A, 1B, and 4B.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Oncogenic KRAS Mutations Confer a Unique Mechanotransduction Response to Peristalsis in Colorectal Cancer Cells
Supplementary Figure 1 shows the gating strategy used for LGR5 analysis in Figures 1A, 1B, and 4B.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 8 from Oncogenic KRAS Mutations Confer a Unique Mechanotransduction Response to Peristalsis in Colorectal Cancer Cells
Supplementary Figure 8 breaks down the heat map of Figure 7 to demonstrate cell line specific statistical differences in Wnt ligand gene expression with MEK inhibition.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 8 from Oncogenic KRAS Mutations Confer a Unique Mechanotransduction Response to Peristalsis in Colorectal Cancer Cells
Supplementary Figure 8 breaks down the heat map of Figure 7 to demonstrate cell line specific statistical differences in Wnt ligand gene expression with MEK inhibition.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 10 from Oncogenic KRAS Mutations Confer a Unique Mechanotransduction Response to Peristalsis in Colorectal Cancer Cells
Supplementary Figure 10 demonstrates LGR5 cancer stem cell enrichment in HCT116 cells exposed to static, shear, strain and peristalsis forces.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 10 from Oncogenic KRAS Mutations Confer a Unique Mechanotransduction Response to Peristalsis in Colorectal Cancer Cells
Supplementary Figure 10 demonstrates LGR5 cancer stem cell enrichment in HCT116 cells exposed to static, shear, strain and peristalsis forces.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Oncogenic KRAS Mutations Confer a Unique Mechanotransduction Response to Peristalsis in Colorectal Cancer Cells
Supplementary Figure 3 shows the gating strategy used for LGR5 analysis in Figure 5B.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Oncogenic KRAS Mutations Confer a Unique Mechanotransduction Response to Peristalsis in Colorectal Cancer Cells
Supplementary Figure 3 shows the gating strategy used for LGR5 analysis in Figure 5B.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Oncogenic KRAS Mutations Confer a Unique Mechanotransduction Response to Peristalsis in Colorectal Cancer Cells
Supplementary Figure 2 shows the gating strategy used for LGR5 analysis in Figures 3A and B.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Oncogenic KRAS Mutations Confer a Unique Mechanotransduction Response to Peristalsis in Colorectal Cancer Cells
Supplementary Figure 2 shows the gating strategy used for LGR5 analysis in Figures 3A and B.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Oncogenic KRAS Mutations Confer a Unique Mechanotransduction Response to Peristalsis in Colorectal Cancer Cells
Supplementary Figure 4 shows the gating strategy used for LGR5 analysis in Figure 6B.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Oncogenic KRAS Mutations Confer a Unique Mechanotransduction Response to Peristalsis in Colorectal Cancer Cells
Supplementary Figure 4 shows the gating strategy used for LGR5 analysis in Figure 6B.